Antihypertensive Drugs

Correct Answer

B — Selective beta-1 adrenergic receptor antagonist

Rationale

Nebivolol is a selective beta-1 adrenergic receptor antagonist. Propranolol is a nonselective beta-adrenergic receptor antagonist. Prazosin is a selective alpha-1 adrenergic receptor antagonist. Methyldopa is a centrally acting alpha-2 adrenergic receptor agonist.

Correct Answer

D — Non-selective beta-adrenergic receptor antagonist combined with alpha-1 adrenergic receptor blockade

Rationale

Carvedilol blocks beta-1 and beta-2 adrenergic receptors (non-selective beta blockade) and also blocks alpha-1 adrenergic receptors in vascular smooth muscle. The combined effect reduces cardiac output through beta-1 blockade while simultaneously reducing total peripheral resistance through alpha-1 vasodilation — a hemodynamic profile that makes it particularly suitable for heart failure with reduced ejection fraction, where both reduced cardiac workload and afterload reduction are beneficial. Carvedilol has proven mortality benefit in severe heart failure with reduced ejection fraction and a neutral to favorable metabolic profile. Labetalol shares this combined alpha-beta mechanism and is the preferred intravenous agent for hypertensive emergencies in pregnancy. Nebivolol is a selective beta-1 agent with nitric oxide-mediated vasodilation. Centrally acting agents such as clonidine and methyldopa reduce sympathetic outflow from the brainstem.

Correct Answer

A — Centrally acting alpha-2 adrenergic receptor agonist

Rationale

Methyldopa is a centrally acting alpha-2 adrenergic receptor agonist. Hydralazine is a direct arteriolar vasodilator. Prazosin is a selective alpha-1 adrenergic receptor antagonist. Losartan is an angiotensin receptor blocker.

Correct Answer

C — Presynaptic alpha-2 adrenergic receptors in the brainstem nucleus tractus solitarius, reducing central sympathetic outflow

Rationale

Clonidine stimulates presynaptic alpha-2 adrenergic receptors in the nucleus tractus solitarius of the brainstem. These receptors act as autoreceptors on sympathetic preganglionic neurons — stimulating them reduces the release of norepinephrine from sympathetic nerve terminals throughout the body. The downstream effects are reduced heart rate and cardiac output, lower total peripheral resistance, and suppressed renin release — all without the direct peripheral vascular or cardiac receptor effects that characterize other antihypertensive classes. This central mechanism explains both its antihypertensive utility and its distinctive adverse effect profile: sedation, dry mouth, bradycardia, and constipation all reflect reduced central and peripheral sympathetic tone. The critical safety concern is abrupt discontinuation, which removes the brake on central sympathetic activity and can produce a severe rebound syndrome.

Correct Answer

B — Direct arteriolar vasodilator

Rationale

Minoxidil is a direct arteriolar vasodilator, the same class as hydralazine. Amlodipine is a calcium channel blocker. Albuterol is a beta-adrenergic receptor agonist. Lisinopril is an angiotensin converting enzyme inhibitor.

Correct Answer

D — Combined alpha and beta-adrenergic receptor antagonist

Rationale

Labetalol is a combined alpha and beta-adrenergic receptor antagonist, blocking beta-1, beta-2, and alpha-1 receptors. Methyldopa is a centrally acting alpha-2 adrenergic receptor agonist. Hydralazine is a direct arteriolar vasodilator. Prazosin is a selective alpha-1 adrenergic receptor antagonist.

Correct Answer

A — Palpitations and tremor are mediated by adrenergic stimulation during hypoglycemia and are blocked by propranolol; diaphoresis is cholinergically mediated and is not affected by beta-adrenergic receptor blockade

Rationale

During hypoglycemia, the adrenal medulla releases epinephrine and the sympathetic nervous system is activated. Many of the warning symptoms that alert a patient to hypoglycemia — tachycardia, palpitations, tremor, anxiety — are driven by adrenergic stimulation of beta-1 and beta-2 receptors. Propranolol, a non-selective beta-adrenergic receptor antagonist, blocks these receptors and prevents these warning symptoms from reaching the patient's awareness. Sweating during hypoglycemia, however, is a cholinergic response mediated by acetylcholine at eccrine sweat glands — not by beta-adrenergic receptors. Because propranolol has no anticholinergic activity, diaphoresis is preserved and remains the one reliable warning sign. Cardioselective beta-blockers such as metoprolol cause less masking of hypoglycemia warnings than non-selective agents because beta-2 receptors in skeletal muscle (tremor) are relatively spared, though some masking still occurs.

Correct Answer

C — Chronic clonidine causes upregulation of alpha-2 receptors; abrupt withdrawal removes the agonist from upregulated receptors, allowing uninhibited catecholamine release from sensitized sympathetic terminals

Rationale

During chronic clonidine therapy, continuous stimulation of presynaptic alpha-2 adrenergic receptors in the brainstem suppresses central sympathetic outflow. Compensatory receptor upregulation occurs — more alpha-2 receptors are expressed. When clonidine is abruptly discontinued, the agonist is removed from these now-upregulated, sensitized receptors. Central sympathetic neurons that were tonically suppressed become suddenly uninhibited, releasing catecholamines in excess. The result is a sympathetic storm: severe rebound hypertension, tachycardia, diaphoresis, and anxiety that can resemble a pheochromocytoma crisis. This reaction is potentially life-threatening. Clonidine should always be tapered over one to two weeks. If withdrawal occurs, the correct response is to restart clonidine immediately by oral or transdermal route. Clonidine should be prescribed with caution in patients with known adherence difficulties.

Correct Answer

B — Slow acetylators have higher plasma hydralazine levels due to reduced hepatic NAT2 enzyme activity, increasing exposure to the drug and its lupus-inducing properties

Rationale

Hydralazine undergoes hepatic acetylation by the N-acetyltransferase 2 (NAT2) enzyme. Individuals who are slow acetylators metabolize hydralazine more slowly, leading to higher sustained plasma concentrations of the parent drug. This increased drug exposure raises the risk of drug-induced lupus — a syndrome presenting with arthralgias, serositis, rash, and a positive antinuclear antibody test with anti-histone antibodies (which distinguish drug-induced lupus from idiopathic systemic lupus erythematosus). The reaction is dose-related and is more common at doses above 200 mg per day in slow acetylators. Fast acetylators metabolize hydralazine more efficiently, reducing plasma exposure and risk. The drug-induced lupus resolves on discontinuation of hydralazine. Hydralazine does not inhibit angiotensin converting enzyme and does not affect bradykinin levels.

Correct Answer

D — A beta-adrenergic receptor antagonist and a loop diuretic — the beta-blocker counters reflex tachycardia and the loop diuretic manages the marked fluid retention; thiazides are insufficient for the degree of sodium retention minoxidil causes

Rationale

Minoxidil is one of the most potent oral vasodilators available, and its profound arteriolar vasodilation triggers two major reflex responses that must be pharmacologically managed. First, the baroreceptor-mediated sympathetic response produces severe reflex tachycardia and increased cardiac output — a beta-adrenergic receptor antagonist is required to blunt this response and prevent dangerous heart rate elevation, which in patients with coronary artery disease can precipitate ischemia. Second, renin-angiotensin-aldosterone system activation and direct renal effects cause marked sodium and water retention — weight gains of 2 to 10 kilograms are expected. This degree of fluid accumulation exceeds what thiazide diuretics can manage; loop diuretics are required because they act at the thick ascending limb and provide substantially greater natriuretic capacity. Prescribing minoxidil without both companion agents creates predictable and serious adverse consequences and is therefore prohibited. Minoxidil is reserved for hypertension refractory to multiple other regimens.

Correct Answer

A — Rapid vasodilation on the venous side of the circulation causes pooling of blood and decreased venous return; the effect is greatest 30 to 90 minutes after the first dose; administering the first dose at bedtime reduces the risk of symptomatic hypotension

Rationale

Alpha-1 adrenergic receptors are present in both arteriolar and venous smooth muscle. When alpha-1 is first blocked in a patient whose vasculature is accustomed to elevated sympathetic tone, both arterial resistance and venous capacitance change rapidly. The venodilation component is especially important: pooling of blood in the venous system reduces venous return and preload, causing a sharp drop in cardiac output and blood pressure. This effect is most pronounced within 30 to 90 minutes of the first dose, before compensatory mechanisms can fully engage. The risk is amplified in volume-depleted patients. Administering the first dose at bedtime while the patient is supine reduces the clinical consequence of this hemodynamic shift — standing hypotension with falls is the principal concern. Starting at the lowest available dose and titrating slowly also reduces the risk. Tolerance develops to the first-dose effect with continued therapy.

Correct Answer

C — Vasodilation without prior beta-blockade triggers reflex sympathetic activation and tachycardia, increasing the rate of aortic pressure rise (dP/dt) and the shear stress on the dissection flap, worsening propagation

Rationale

In acute aortic dissection, the primary goal of pharmacological therapy is to reduce aortic wall stress. The key hemodynamic target is the rate of aortic pressure rise — termed dP/dt — which is the primary determinant of mechanical shear force on the dissection flap. Rapid, forceful cardiac contractions with high heart rate generate high dP/dt and propagate the dissection. Vasodilators lower blood pressure but trigger reflex sympathetic activation, raising heart rate and myocardial contractility — both of which increase dP/dt and worsen the dissection despite a lower mean pressure. A beta-adrenergic receptor antagonist must be established first to reduce heart rate and dP/dt before any vasodilator is added. The target is a heart rate below 60 beats per minute, achieved with intravenous esmolol or labetalol. Only after this is achieved should a vasodilator be added to bring systolic blood pressure below 120 millimeters of mercury.

Correct Answer

B — A positive Coombs test occurs in up to 20 percent of patients on long-term methyldopa; clinically significant hemolytic anemia is uncommon, and the test alone does not require discontinuation if the patient is asymptomatic

Rationale

Methyldopa is associated with a positive direct Coombs test in up to 20 percent of patients on long-term therapy. The mechanism involves methyldopa or its metabolites stimulating the production of autoantibodies directed against red blood cell surface antigens — particularly the Rh system — which are then detected by the Coombs reagent. Clinically significant hemolytic anemia from these antibodies is uncommon; most patients with a positive test have no measurable hemolysis. A positive Coombs test alone, in an asymptomatic patient with a normal complete blood count, does not require immediate discontinuation. The drug should be discontinued if hemolytic anemia develops. Other autoimmune adverse effects of methyldopa include drug-induced lupus and, rarely, hepatotoxicity. Despite these potential adverse effects, methyldopa remains in clinical use in pregnancy because decades of data confirm its fetal safety, and the autoimmune adverse effects are manageable with monitoring.

Correct Answer

D — Sodium nitroprusside releases cyanide as it spontaneously degrades; with prolonged infusion above 48 hours or high doses, cyanide accumulation can cause toxicity — this risk and the availability of safer alternatives have led to its decreased use

Rationale

Sodium nitroprusside spontaneously releases nitric oxide, producing rapid and titratable balanced arteriolar and venous dilation. However, its degradation also releases cyanide ions as a byproduct. Cyanide is normally metabolized by the liver to thiocyanate, but this capacity is finite. With infusion rates above recommended limits or infusions lasting beyond approximately 48 hours, cyanide can accumulate, inhibiting cytochrome c oxidase in the mitochondrial electron transport chain and causing cellular hypoxia. Cyanide toxicity presents with lactic acidosis, altered consciousness, and cardiovascular collapse. Because intravenous nicardipine (a dihydropyridine calcium channel blocker) and labetalol provide similarly rapid and titratable blood pressure control without this metabolic risk, they have largely replaced sodium nitroprusside for most hypertensive emergencies. Sodium nitroprusside retains use in specific situations such as acute pulmonary edema with severe hypertension when rapid combined arteriolar and venous dilation is needed.

Correct Answer

C — Propranolol blocks beta-adrenergic receptors, masking adrenergically mediated warnings such as tachycardia and tremor; diaphoresis is preserved because sweating is cholinergically mediated and unaffected by beta blockade

Rationale

During hypoglycemia, the body activates the sympathoadrenal response — epinephrine is released and sympathetic nerves fire, generating the warning symptoms that alert the patient to the low glucose. Tachycardia and palpitations arise from cardiac beta-1 receptor stimulation; tremor arises from skeletal muscle beta-2 receptor stimulation. Propranolol blocks both beta-1 and beta-2 receptors, eliminating these adrenergic warning signals. Diaphoresis during hypoglycemia is mediated by acetylcholine at eccrine sweat glands — a cholinergic pathway that is not blocked by beta-adrenergic receptor antagonists. This explains the pattern seen in this patient: absent palpitations and tremor (adrenergic, blocked), preserved sweating (cholinergic, intact). Propranolol also impairs hepatic glycogenolysis through beta-2 blockade in hepatocytes, potentially prolonging hypoglycemia after insulin excess. For diabetic patients who need a beta-blocker, cardioselective agents such as metoprolol cause less masking because beta-2 receptor effects are relatively spared.

Correct Answer

A — Abrupt clonidine withdrawal causes sympathetic rebound from upregulated alpha-2 receptors now without their agonist; the correct treatment is to restart clonidine immediately

Rationale

The timing — four days after stopping clonidine abruptly — and the pattern of severe hypertension with tachycardia, diaphoresis, and anxiety are characteristic of clonidine withdrawal syndrome. During chronic therapy, alpha-2 adrenergic receptors in the brainstem are tonically stimulated, and compensatory receptor upregulation occurs. When clonidine is abruptly removed, these now-sensitized, upregulated receptors lose their agonist, and central sympathetic inhibition is lost. The resulting sympathetic surge resembles a pheochromocytoma crisis clinically — the key distinguishing feature is the history of recent clonidine discontinuation. The most appropriate immediate intervention is to restart clonidine by oral or transdermal route, which restores central sympathetic suppression. Intravenous antihypertensives may also be needed for acute blood pressure control, but restarting clonidine addresses the mechanism. This case illustrates why clonidine should be prescribed with caution in patients with adherence difficulties and should always be tapered rather than stopped abruptly.

Correct Answer

D — Minoxidil-induced vasodilation triggered reflex tachycardia and marked sodium retention; a beta-adrenergic receptor antagonist to counter tachycardia and a loop diuretic — not a thiazide, which is insufficient — to manage the degree of fluid retention were required

Rationale

Minoxidil's profound arteriolar vasodilation activates two predictable reflex responses. The baroreceptor-mediated sympathetic surge produces tachycardia (heart rate 118 beats per minute in this patient) and increased cardiac output that partly offsets the intended blood pressure reduction. A beta-adrenergic receptor antagonist is required to suppress this reflex. Simultaneously, renin-angiotensin-aldosterone system activation and direct renal effects cause marked sodium and water retention — weight gains of 2 to 10 kilograms are expected without a diuretic. Thiazide diuretics do not provide sufficient natriuretic capacity for the degree of retention minoxidil produces; a loop diuretic is mandatory. These two companion requirements (beta-blocker and loop diuretic) are absolute when minoxidil is prescribed and must not be omitted. The inadequate blood pressure reduction in this patient results from reflex cardiac output increase and volume expansion counteracting the vasodilation — both problems resolve with appropriate companion therapy.

Correct Answer

B — Beta-adrenergic receptor antagonists remove the vasodilatory beta-2 adrenergic tone while leaving cocaine-driven alpha-1 vasoconstriction unopposed, worsening hypertension and coronary spasm; benzodiazepines are preferred first-line, with phentolamine for refractory hypertension

Rationale

Cocaine causes hypertension by blocking norepinephrine reuptake at sympathetic nerve terminals, flooding adrenergic receptors. Both alpha-1 (vasoconstriction) and beta-2 (vasodilation) receptor activation occur simultaneously. When a beta-adrenergic receptor antagonist is given, beta-2-mediated vasodilation is removed while alpha-1-mediated vasoconstriction from the cocaine-norepinephrine surge continues unopposed. The net effect is paradoxical worsening of hypertension and potentially severe coronary artery spasm — the same mechanism that makes beta-blockers dangerous in pheochromocytoma. Benzodiazepines are the preferred first-line treatment because they reduce central sympathetic drive by enhancing gamma-aminobutyric acid-mediated inhibition, addressing the anxiety and agitation that amplify the sympathetic response. For refractory hypertension after benzodiazepines, phentolamine — a non-selective alpha-adrenergic receptor antagonist — directly counters the alpha-1 vasoconstriction. Labetalol, which combines alpha and beta blockade, is also generally avoided because its beta component still risks the unopposed alpha problem at the tissue level.